Abbott's Humira Positive in 2 Studies
13th Nov 2006, 22:28 GMT
Recent studies of Abbott Labs' anti-inflammatory drug Humira indicate it does not hurt the effectiveness of flu vaccinations in patients with rheumatoid arthritis and may be effective in treating children.
Abbott's Humira Positive in 2 Studies related news:
- Abbott's Humira gets expanded indication — United Press International - Health Business
- FDA Expands Use of Abbott's Humira — Government/ Industry Regulation News from StratCenter.com
- Abbott Begins Kos Tender Offer — Financial News News from StratCenter.com
- ACR: Humira Shows 'Profound' Benefit for Kids With Rheumatoid Arthritis — MedPage Today Pediatrics
- Abbott's HUMIRA Receives FDA Approval for Inhibiting Structural Joint Damage and Improving Physical Function in Patients With Psoriatic Arthritis — Government/ Industry Regulation News from StratCenter.com
- Abbott Labs Commences Tender Offer for All Outstanding Shares of Kos Pharmaceuticals — StratWire - Business of Healthcare NewsFeed
- Uniforms Create Positive 'Halos' for Workers — PR Newswire: All Releases
- Studies of Vioxx Replacement Drawing Criticism — TIME Magazine Online: Top Science and Health Stories
- Traditional Books Provide More Positive Parent-Child Interaction — Health News from Medical News Today
- Studies Look At Diet's Ties To Cancer, Heart Risks — wnbc.com - Health
Latest news from Operations-Related News from StratCenter.com:
- Senior Housing Properties Trust Announces Proposed Public Offering of 5 mln Common Shares
- King Not Loving Its Shareholders
- Sepracor says asthma drug data is favorable
- Sepracor Presents Data on Asthma Drug
- Dr Reddy's Registers to List Shares
- PolyMedica Corp CEO to Ring the NASDAQ Stock Market Opening Bell
- Biovail to Present at the CSFB 2006 Healthcare Conference
- Genelabs reports lower Q3 loss
- Solexa posts narrowed Q3 loss
- Kos' Swan Song